1. Disposition, metabolism and mass balance of delafloxacin in healthy human volunteers following intravenous administration. (2nd December 2015) Authors: McEwen, Andrew; Lawrence, Laura; Hoover, Randy; Stevens, Lloyd; Mair, Stuart; Ford, Gill; Williams, Dylan; Wood, Stuart Journal: Xenobiotica Issue: Volume 45:Number 12(2015:Dec.) Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study. (6th March 2018) Authors: O'Riordan, William; McManus, Alison; Teras, Juri; Poromanski, Ivan; Cruz-Saldariagga, Maria; Quintas, Megan; Lawrence, Laura; Liang, ShuJui; Cammarata, Sue Journal: Clinical infectious diseases Issue: Volume 67:Number 5(2018) Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP). (5th December 2019) Authors: Horcajada, Juan P; Salata, Robert A; Álvarez-Sala, Rodolfo; Nitu, Floarea Mimi; Lawrence, Laura; Quintas, Megan; Cheng, Chun-Yen; Cammarata, Sue Other Names: other. Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial. (August 2020) Authors: McCurdy, Sandra; Nenninger, Ashley; Sheets, Amanda; Keedy, Kara; Lawrence, Laura; Quintas, Megan; Cammarata, Sue Journal: International journal of infectious diseases Issue: Volume 97(2020) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens. (4th October 2017) Authors: Overcash, Scott; O'Riordan, William; Lawrence, Laura; McCurdy, Sandra P; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens. (4th October 2017) Authors: O'Riordan, William; Overcash, Scott; Lawrence, Laura; McCurdy, Sandra P; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of Delafloxacin (DLX) and Vancomycin/Aztreonam (VAN/AZ) on Resolution of Signs and Symptoms of Acute Bacterial Skin and Skin Structure Infections (ABSSSI). (4th October 2017) Authors: Giordano, Philip; Pullman, John; Lawrence, Laura; Quintas, Megan; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy. (26th November 2018) Authors: Pullman, John; O'Riordan, William; Lawrence, Laura; Quintas, Megan; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ). (26th November 2018) Authors: Oguchi, Godson; Beasley, Richard; Lawrence, Laura; Tseng, Carol; Cammarata, Sue K Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment. (26th March 2018) Authors: Hoover, Randall K.; Alcorn, Harry; Lawrence, Laura; Paulson, Susan K.; Quintas, Megan; Luke, David R.; Cammarata, Sue K. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 6(2018) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗